NCT05573568View on ClinicalTrials.gov

Clinical Study of DMT in Healthy Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

27

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

November 1, 2022

Study Completion Date

November 14, 2022

Conditions

Healthy Volunteers

Interventions

DRUG

N,N-Dimethyltryptamine

DMT will be administered using a vaporizer device in a single ascending fixed-order dosing regimen

Trial Locations (1)

59012300

Hospital Universitário Onofre Lopes, Natal

Sponsors

Lead Sponsor

Biomind Labs Inc.

All Listed Sponsors

collaborator

Universidade Federal do Rio Grande do Norte

OTHER

lead

Biomind Labs Inc.

INDUSTRY

NCT05573568 - Clinical Study of DMT in Healthy Adults | Biotech Hunter | Biotech Hunter